Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 5.80 · gapped above the open, then crossed back over prior close. High/low 5.91 at 8:00 am ET, 5.65 at 11:15 am ET.
Nuvation Bio Inc. has 1 disclosed supplier and 3 disclosed customers. Each one is named in an SEC filing, either Nuvation Bio Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In December 2018, AnHeart Therapeutics Inc. ("AHT"), a wholly owned subsidiary of AnHeart, entered into a license agreement with Daiichi Sankyo Company, Limited ("Daiichi Sankyo"), pursuant to which Daiichi Sankyo granted to AHT exclusive worldwide rights to develop and commercialize taletrectinib (the "Taletrectinib In-License Agreement").”
FILING10-K0001193125-26-085584cik 0001811063
“In January 2026, we announced a partnership with Eisai Co., Ltd. ("Eisai") to commercialize taletrectinib in Europe and other territories outside the U.S., China and Japan.”
FILING10-K0001193125-26-085584cik 0001811063
“Taletrectinib is being commercialized in Japan by our partner Nippon Kayaku Co., Ltd ("NK") under the brand name IBTROZI and in China by our partner Innovent Biologics (Suzhou) Co. Ltd. ("Innovent") under the brand name DOVBLERON®.”
FILING10-K0001193125-26-085584cik 0001811063
“Taletrectinib is being commercialized in Japan by our partner Nippon Kayaku Co., Ltd ("NK") under the brand name IBTROZI and in China by our partner Innovent Biologics (Suzhou) Co. Ltd. ("Innovent") under the brand name DOVBLERON®.”
FILING10-K0001193125-26-085584cik 0001811063
Watchlist prices, news filtered to it, and its next report on your desk.
Nuvation Bio Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Pharmaceutical Preparations
NUVB (Nuvation Bio Inc.) has 1 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.